Biology of Blood and Marrow Transplantation
Volume 16, Issue 6 , Pages 772-781 , June 2010

Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses

  • Bo Hu

      Affiliations

    • Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, People's Republic of China
    • ,
  • Yan He

      Affiliations

    • Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, People's Republic of China
    • ,
  • Yan Wu

      Affiliations

    • Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, People's Republic of China
    • ,
  • Guangming Bao

      Affiliations

    • Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, People's Republic of China
    • ,
  • Haiyan Liu

      Affiliations

    • Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, People's Republic of China
    • Thrombosis and Hemostasis Key Lab of the Ministry of Health; Soochow University, Suzhou, People's Republic of China
    • Corresponding Author InformationCorrespondence and reprint requests: Haiyan Liu, PhD, Laboratory of Cellular and Molecular Tumor Immunology, Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou, Jiangsu 215123, People's Republic of China.
    • ,
  • Lisbeth A. Welniak

      Affiliations

    • Department of Microbiology and Immunology, University of Nevada, Reno, Nevada
    • ,
  • William J. Murphy

      Affiliations

    • Department of Microbiology and Immunology, University of Nevada, Reno, Nevada

Received 29 August 2009 ,Accepted 23 February 2010.

References 

  1. Blume KG, Forman SJ, Appelbaum FR. Hematopoietic Cell Transplantation. 3rd ed.. Malden, MA: Blackwell Science; 2004;
  2. Copelan EA. Hematopoietic stem cell transplantation. N Engl J Med. 2006;354:1813–1826
  3. Yuan D, Wilder J, Dang T, Bennett M, Kumar V. Activation of B lymphocytes by NK cells. Int Immunol. 1992;4:1373–1380
  4. Ortaldo JR, Mason LH, Gregorio TA, Stoll J, Winkler-Pickett RT. The Ly-49 family: regulation of cytokine production in murine NK cells. J Leukoc Biol. 1997;62:381–388
  5. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med. 1987;166:1499–1509
  6. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–2100
  7. Murphy WJ, Bennett M, Kumar V, Longo DL. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J Immunol. 1992;148:2953–2960
  8. Asai O, Longo DL, Tian ZG, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest. 1998;101:1835–1842
  9. Azuma E, Yamamoto H, Kaplan J. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. J Immunol. 1989;143:1524–1529
  10. Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature. 1980;287:544–546
  11. Miller RG. Lymphoid suppressor cells. In:  Sercarz EE,  Cunningham AJ editor. Strategies of Immune Regulation. New York: Academic Press; 1980;p. 507
  12. Miller RG, Derry H. A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol. 1979;122:1502–1509
  13. Muraoka S, Miller RG. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med. 1980;152:54–71
  14. Reich-Zeliger S, Gan J, Bachar-Lustig E, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. J Immunol. 2004;173:6660–6666
  15. Hiruma K, Nakamura H, Henkart PA, Gress RE. Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes. J Exp Med. 1992;175:863–868
  16. Kägi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 1994;265:528–530
  17. Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S. Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J Immunol. 1997;158:136–143
  18. Velardi A, Ruggeri L, Alessandro , Moretta , Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 2002;23:438–444
  19. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333–339
  20. Reich-Zeliger S, Bachar-Lustig E, Gan J, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells. J Immunol. 2004;173:6654–6659
  21. Nishimura R, Baker J, Beilhack A, et al. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood. 2008;112:2563–2574
  22. Deniz G, Erten G, Kücüksezer UC, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol. 2008;180:850–857
  23. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 1994;370:650–652
  24. Nagata S. Apoptosis by death factor. Cell. 1997;88:355–365
  25. Lincz LF. Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol. 1998;76:1–19
  26. Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol. 1998;10:559–563
  27. Mariani SM, Krammer PH. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol. 1998;28:1492–1498
  28. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med. 1998;188:2375–2380
  29. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med. 1999;189:1343–1354
  30. Kwon B, Youn BS, Kwon BS. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol. 1999;11:340–345
  31. Golstein P. Cell death: TRAIL and its receptors. Curr Biol. 1997;7:R750–R753

 Current address of William J. Murphy: Department of Dermatology, School of Medicine, University of California, Davis, CA.

 Financial disclosure: See Acknowledgments on page 781.

PII: S1083-8791(10)00096-0

doi: 10.1016/j.bbmt.2010.02.023

Biology of Blood and Marrow Transplantation
Volume 16, Issue 6 , Pages 772-781 , June 2010

Article Tools

* Image Usage & Resolution